revealed that CCT3 is a new complementary biomarker for HCC screening and diagnosis (50). Several studies have shown that CCT3 is overexpressed in HCC patients by quantitative RT-PCR and western blotting. This evidence concerns the gene CCT3 and hepatocellular carcinoma.